Bionano Genomics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 14 →Insiders1 insider bought $9,720 in 2 open-market buys. No sales.→HoldersCarret 1.1%Geode 0.8%Vanguard 0.7%→Financing →PeersClosest companies: PSNL, CTKB, QSI→
From the filings
Figures
- Revenue
- $30.2Mlast 12 months
- Net income
- −$32.2Mlast 12 months
- Operating cash flow
- −$19.3Mlast 12 months
- Cash and equivalents
- $3.7Mat the last balance sheet
- Shares outstanding
- 11.8M shareson issue